Susquehanna International Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.06M | Buy |
1,304,685
+598,270
| +85% | +$1.01M | ﹤0.01% | 6121 |
|
|
2025
Q4 | $1.18M | Buy |
706,415
+521,415
| +282% | +$902K | ﹤0.01% | 6817 |
|
|
2025
Q3 | $313K | Sell |
185,000
-362,242
| -66% | -$429K | ﹤0.01% | 10013 |
|
|
2025
Q2 | $497K | Buy |
547,242
+311,133
| +132% | +$185K | ﹤0.01% | 9190 |
|
|
2025
Q1 | $107K | Buy |
236,109
+172,795
| +273% | +$101K | ﹤0.01% | 11496 |
|
|
2024
Q4 | $31.8K | Buy |
63,314
+52,318
| +476% | +$38.4K | ﹤0.01% | 11826 |
|
|
2024
Q3 | $9.96K | Sell |
10,996
-60,326
| -85% | -$55.9K | ﹤0.01% | 11721 |
|
|
2024
Q2 | $71.1K | Buy |
71,322
+36,017
| +102% | +$39.8K | ﹤0.01% | 11237 |
|
|
2024
Q1 | $52.3K | Sell |
35,305
-25,774
| -42% | -$29.2K | ﹤0.01% | 11549 |
|
|
2023
Q4 | $66.6K | Buy |
+61,079
| New | +$66.9K | ﹤0.01% | 11580 |
|
|
2023
Q3 | – | Sell |
-41,181
| Closed | -$56K | – | 12635 |
|
|
2023
Q2 | $58.1K | Sell |
41,181
-775,206
| -95% | -$1.07M | ﹤0.01% | 11274 |
|
|
2023
Q1 | $1.22M | Buy |
816,387
+642,768
| +370% | +$897K | ﹤0.01% | 6285 |
|
|
2022
Q4 | $203K | Buy |
+173,619
| New | +$219K | ﹤0.01% | 10088 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 13821 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 13623 |
|
|
2022
Q1 | – | Sell |
-66,430
| Closed | -$103K | – | 13662 |
|
|
2021
Q4 | $163K | Sell |
66,430
-53,271
| -45% | -$125K | ﹤0.01% | 11695 |
|
|
2021
Q3 | $302K | Buy |
119,701
+46,982
| +65% | +$121K | ﹤0.01% | 10589 |
|
|
2021
Q2 | $207K | Sell |
72,719
-927,463
| -93% | -$2.4M | ﹤0.01% | 11532 |
|
|
2021
Q1 | $2.35M | Buy |
1,000,182
+863,839
| +634% | +$2.07M | ﹤0.01% | 5530 |
|
|
2020
Q4 | $240K | Buy |
+136,343
| New | +$191K | ﹤0.01% | 9734 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 10980 |
|
|
2020
Q2 | – | Sell |
-29,981
| Closed | -$26.4K | – | 10643 |
|
|
2020
Q1 | $25K | Sell |
29,981
-29,310
| -49% | -$29.2K | ﹤0.01% | 9885 |
|
|
2019
Q4 | $53K | Sell |
59,291
-7,029
| -11% | -$5.86K | ﹤0.01% | 9328 |
|
|
2019
Q3 | $65K | Sell |
66,320
-43,670
| -40% | -$45.2K | ﹤0.01% | 9708 |
|
|
2019
Q2 | $121K | Buy |
109,990
+37,370
| +51% | +$43.1K | ﹤0.01% | 9514 |
|
|
2019
Q1 | $95K | Buy |
+72,620
| New | +$90.3K | ﹤0.01% | 8269 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 9884 |
|
|
2018
Q3 | – | Sell |
-34,690
| Closed | -$63K | – | 10124 |
|
|
2018
Q2 | $63K | Buy |
34,690
+3,944
| +13% | +$7.94K | ﹤0.01% | 9211 |
|
|
2018
Q1 | $72K | Sell |
30,746
-67,670
| -69% | -$159K | ﹤0.01% | 8833 |
|
|
2017
Q4 | $185K | Buy |
+98,416
| New | +$215K | ﹤0.01% | 8339 |
|
|
2017
Q3 | – | Sell |
-41,960
| Closed | -$104K | – | 9533 |
|
|
2017
Q2 | $116K | Sell |
41,960
-10,881
| -21% | -$30.4K | ﹤0.01% | 8618 |
|
|
2017
Q1 | $159K | Sell |
52,841
-94,211
| -64% | -$268K | ﹤0.01% | 8158 |
|
|
2016
Q4 | $464K | Buy |
147,052
+119,051
| +425% | +$366K | ﹤0.01% | 7157 |
|
|
2016
Q3 | $96K | Buy |
28,001
+10,488
| +60% | +$29K | ﹤0.01% | 7958 |
|
|
2016
Q2 | $40K | Buy |
+17,513
| New | +$42.9K | ﹤0.01% | 8281 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 9450 |
|
|
2015
Q4 | – | Sell |
-64,116
| Closed | -$192K | – | 9767 |
|
|
2015
Q3 | $155K | Buy |
64,116
+27,900
| +77% | +$72.2K | ﹤0.01% | 8898 |
|
|
2015
Q2 | $106K | Sell |
36,216
-16,840
| -32% | -$65.3K | ﹤0.01% | 9643 |
|
|
2015
Q1 | $213K | Buy |
53,056
+21,011
| +66% | +$72.7K | ﹤0.01% | 8540 |
|
|
2014
Q4 | $96K | Sell |
32,045
-10,793
| -25% | -$29.2K | ﹤0.01% | 9202 |
|
|
2014
Q3 | $109K | Sell |
42,838
-14,526
| -25% | -$35K | ﹤0.01% | 9044 |
|
|
2014
Q2 | $141K | Buy |
+57,364
| New | +$130K | ﹤0.01% | 9277 |
|
|
2014
Q1 | – | Sell |
-14,733
| Closed | -$43.4K | – | 9240 |
|
|
2013
Q4 | $43K | Buy |
+14,733
| New | +$44.5K | ﹤0.01% | 8827 |
|
|
2013
Q3 | – | Sell |
-44,498
| Closed | -$141K | – | 8691 |
|
|
2013
Q2 | $142K | Buy |
+44,498
| New | +$143K | ﹤0.01% | 7658 |
|
Other funds holding LCTX
BC
VCM
DC
RA
AC
